ASK THE EXPERT

 

 

Each month, we ask a breast cancer expert to respond to your questions on a specific topic during an ask-the-expert residency. Answers to select questions will be posted to our website on an ongoing basis throughout the month.

 

The topic for the month of April is:

 

Research and Treatments for Triple-Negative Breast Cancer

 

 

If you have questions about treatment options for TNBC, how to access clinical trials or what you should ask your healthcare team, ask our expert, George Sledge, MD, your question using the form below.

 

While we make an effort to ask as many questions as we can, we are unable to answer all questions that are submitted. Dr. Sledge will answer questions on an ongoing basis throughout April; check back for updates.

 

If you have an urgent question or would like to speak to someone in person, please call our Survivors’ Helpline at (888) 753-LBBC (5222).

 

 

About Our Expert

 

George W. Sledge, MD, is a professor of medicine and pathology and chief of the division of oncology at Stanford University's School of Medicine. He was previously the Ballvé-Lantero professor of oncology and co-chair of the breast cancer program at Indiana University School of Medicine. A leader in researching new treatments for breast cancer, Dr. Sledge has published extensively in the area of breast cancer research and has chaired several nationwide clinical trials involving new therapies for breast 
 

 

Please do not submit any highly personal or identifying information (name, address, etc.) in your question. And remember: we cannot provide diagnoses, medical consultations or specific treatment recommendations. This service is designed for educational and informational purposes only. The information is general in nature. For specific healthcare questions or concerns, consult your healthcare provider because treatment varies with individual circumstances. The content is not intended in any way to substitute for professional counseling or medical advice.

 

Your First Name 
First Question:
Second Question:
Third Question: